- Home
- AARD vs PERF Comparison
AARD vs PERF Comparison
Compare AARD & PERF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AARD
- PERF
- Stock Information
- Founded
- AARD 2017
- PERF 2015
- Country
- AARD United States
- PERF Taiwan
- Employees
- AARD N/A
- PERF N/A
- Industry
- AARD Biotechnology: Pharmaceutical Preparations
- PERF Computer Software: Prepackaged Software
- Sector
- AARD Health Care
- PERF Technology
- Exchange
- AARD Nasdaq
- PERF Nasdaq
- Market Cap
- AARD 231.9M
- PERF 187.4M
- IPO Year
- AARD 2025
- PERF N/A
- Fundamental
- Price
- AARD $9.91
- PERF $1.86
- Analyst Decision
- AARD Strong Buy
- PERF
- Analyst Count
- AARD 8
- PERF 0
- Target Price
- AARD $30.63
- PERF N/A
- AVG Volume (30 Days)
- AARD 162.6K
- PERF 165.0K
- Earning Date
- AARD 11-13-2025
- PERF 10-28-2025
- Dividend Yield
- AARD N/A
- PERF N/A
- EPS Growth
- AARD N/A
- PERF 8.89
- EPS
- AARD N/A
- PERF 0.06
- Revenue
- AARD N/A
- PERF $66,900,999.00
- Revenue This Year
- AARD N/A
- PERF $16.49
- Revenue Next Year
- AARD N/A
- PERF $15.05
- P/E Ratio
- AARD N/A
- PERF $33.29
- Revenue Growth
- AARD N/A
- PERF 14.47
- 52 Week Low
- AARD $4.88
- PERF $1.51
- 52 Week High
- AARD $19.58
- PERF $3.44
- Technical
- Relative Strength Index (RSI)
- AARD 39.27
- PERF 43.57
- Support Level
- AARD $9.34
- PERF $1.80
- Resistance Level
- AARD $11.51
- PERF $1.94
- Average True Range (ATR)
- AARD 0.85
- PERF 0.10
- MACD
- AARD -0.01
- PERF -0.01
- Stochastic Oscillator
- AARD 20.39
- PERF 11.43
About AARD Aardvark Therapeutics Inc.
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.
About PERF Perfect Corp.
Perfect Corp is engaged in the beauty and fashion tech revolution, providing omni-channel integrated solutions. The company runs a hybrid business model of direct consumer business (B2C business) and enterprise business (B2B business). For B2C businesses, the company offers six mobile apps under the "YouCam" suite, along with one online editing service tool, YouCam Online Editor, featuring AI and AR technologies. For B2B businesses, the company offers AI and AR-powered solutions tailored for the beauty and fashion industry. Geographically, the company has a presence in the United States, Americas-other, France, Japan, and Others. The company generates the majority of its revenue from the United States.